National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

This is VAERS ID 1724672

Government Disclaimer on use of this data



Case Details

VAERS ID: 1724672 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-09-09
Onset:2021-09-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-09-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Fatigue, Headache, Influenza like illness, Pain, Pain in extremity, SARS-CoV-2 test
SMQs:, Guillain-Barre syndrome (broad), Tendinopathies and ligament disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Test Result: Negative ; Comments: No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC202101191475

Write-up: Fatigue; Pains in legs; Headache; Flu like symptoms; Body aching; Feels like a lack of energy; This is a spontaneous report from a contactable consumer or other non HCP. This is a report received from the Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202109101901280500-49RRF, Safety Report Unique Identifier GB-MHRA-ADR 25925557. A 18-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on 09Sep2021 as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection), via an unspecified route of administration on unspecified date (Lot number was not reported) as dose 1, single for COVID-19 immunization. Patient was not test positive for COVID-19 since having the vaccine. Patient was not enrolled in clinical trial. Patient did not had symptoms associated with COVID-19, Patient was not pregnant, Patient was not currently breastfeeding. Initially after receiving a vaccine patient was fine. On 10Sep2021, 1 day after second dose the patient experienced fatigue, pains in legs, headache, flu like symptoms, body aching, feels like a lack of energy. The events were reported as medically significant. it was reported that After waking up next morning patient whole body hurts struggle to stand for long time almost flu like symptoms in regards to body aching- Feels like a lack of energy patient had a strong headache also. The patient underwent lab tests and procedures which included sars-cov-2 test: negative (No - Negative COVID-19 test) on unspecified date. The outcome of the events fatigue, pains in legs, headache were recovering and outcome of other events were unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1724672


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166